Sergei Vatolin

Sergei Vatolin is a professional involved in the design and development of assays aimed at rapidly identifying innovative anti-aging and anti-cancer products with a focus on extending replicative and chronological lifespans in various organisms and promoting stem cell regeneration in both mouse and human bone marrow.

He has identified highly effective anti-aging drugs that operate through distinct mechanisms of action, with the overarching objective of developing a new category of drugs to enhance the regeneration of the bone marrow stem cell compartment, extend chronological lifespan in mammals, and create combination therapies for pharmacological, conditional immortalization.

Education-wise, Sergei pursued a Doctor of Philosophy (Ph.D.) in Molecular Genetics from the Institute of Cytology and Genetics in Novosibirsk, Russia, and also completed a Master's Degree in Biology/Biological Sciences at Novosibirsk State University (NSU).

With regards to his professional experience, he has held roles such as Staff Research Scientist and Lab Manager at Case Western Reserve University, Project Staff Scientist at Cleveland Clinic, Senior Scientist at CUBRC, Researcher at Cleveland Clinic, Postdoctoral Fellow at National Institutes of Health, NIAID, Research Scientist at Laboratory of Molecular Biology of Bacterial Pathogens in the Institute of Microbiology, and Scientist at the Institute of Cytology and Genetics.